UCLA's School of Dentistry and South Korean firm Dongwoon Anatech have forged a $2.4 million collaboration to develop saliva-based liquid biopsy technologies. The partnership aims to create a cartridge-based point-of-care device for detecting cancer biomarkers, including those associated with lung and oral cancers, leveraging UCLA's Electric Field-Induced Release and Measurement (EFIRM) platform for rapid, sensitive diagnostics.